151 related articles for article (PubMed ID: 36642639)
21. Postoperative renal function after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease: a comparison with radical nephrectomy.
Takagi T; Kondo T; Iizuka J; Kobayashi H; Hashimoto Y; Nakazawa H; Ito F; Tanabe K
Int J Urol; 2011 Jun; 18(6):472-6. PubMed ID: 21481013
[TBL] [Abstract][Full Text] [Related]
22. Predicting short- and long-term renal function following partial and radical nephrectomy.
Roussel E; Laenen A; Bhindi B; De Dobbeleer A; Stichele AV; Verbeke L; Van Cleynenbreugel B; Sprangers B; Beuselinck B; Van Poppel H; Joniau S; Albersen M
Urol Oncol; 2023 Feb; 41(2):110.e1-110.e6. PubMed ID: 36372636
[TBL] [Abstract][Full Text] [Related]
23. Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end-stage renal disease (ESRD).
Yap SA; Finelli A; Urbach DR; Tomlinson GA; Alibhai SM
BJU Int; 2015 Jun; 115(6):897-906. PubMed ID: 25065448
[TBL] [Abstract][Full Text] [Related]
24. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S; Eldefrawy A; Ghali F; Meagher MF; Hamilton ZA; Yim K; Nasseri R; Bradshaw AW; Dey S; Kirmiz S; Wan F; Liss MA; Bensalah K; Montorsi F; Derweesh IH
Clin Genitourin Cancer; 2020 Dec; 18(6):e723-e729. PubMed ID: 32600941
[TBL] [Abstract][Full Text] [Related]
25. Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgery.
Satasivam P; Reeves F; Rao K; Ivey Z; Basto M; Yip M; Roth H; Grummet J; Goad J; Moon D; Murphy D; Appu S; Lawrentschuk N; Bolton D; Kearsley J; Costello A; Frydenberg M
BJU Int; 2015 Oct; 116(4):590-5. PubMed ID: 25676543
[TBL] [Abstract][Full Text] [Related]
26. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.
An JY; Ball MW; Gorin MA; Hong JJ; Johnson MH; Pavlovich CP; Allaf ME; Pierorazio PM
Urology; 2017 Feb; 100():151-157. PubMed ID: 27889493
[TBL] [Abstract][Full Text] [Related]
27. Kidney function following partial or radical nephrectomy for renal cell carcinoma: a population-based study.
Mariusdottir E; Jonsson E; Marteinsson VT; Sigurdsson MI; Gudbjartsson T
Scand J Urol; 2013 Dec; 47(6):476-82. PubMed ID: 23597159
[TBL] [Abstract][Full Text] [Related]
28. Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma.
Schmid M; Abd-El-Barr AE; Gandaglia G; Sood A; Olugbade K; Ruhotina N; Sammon JD; Varda B; Chang SL; Kibel AS; Chun FK; Menon M; Fisch M; Trinh QD
Urol Oncol; 2014 Nov; 32(8):1259-66. PubMed ID: 25129142
[TBL] [Abstract][Full Text] [Related]
29. Renal and major clinical outcomes and their determinants after nephrectomy in patients with pre-existing chronic kidney disease: A retrospective cohort study.
Schleef M; Roy P; Lemoine S; Paparel P; Colombel M; Badet L; Guebre-Egziabher F
PLoS One; 2024; 19(5):e0300367. PubMed ID: 38696458
[TBL] [Abstract][Full Text] [Related]
30. Partial versus Radical Nephrectomy for T1-T2 Renal Cell Carcinoma in Patients with Chronic Kidney Disease Stage III: a Multiinstitutional Analysis of Kidney Function and Survival Rate.
Chung JS; Son NH; Lee SE; Hong SK; Jeong CW; Kwak C; Kim HH; Hong SH; Kim YJ; Kang SH; Chung J; Kwon TG; Hwang EC; Byun SS
J Korean Med Sci; 2018 Oct; 33(43):e277. PubMed ID: 30344463
[TBL] [Abstract][Full Text] [Related]
31. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.
Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA
Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471
[TBL] [Abstract][Full Text] [Related]
32. Value of Partial Nephrectomy for Renal Cortical Tumors of cT2 or Greater Stage: A Risk-benefit Analysis of Renal Function Preservation Versus Increased Postoperative Morbidity.
Vilaseca A; Guglielmetti G; Vertosick EA; Sjoberg DD; Grasso A; Benfante NE; Nguyen DP; Corradi RB; Coleman J; Russo P; Vickers AJ; Touijer KA
Eur Urol Oncol; 2020 Jun; 3(3):365-371. PubMed ID: 31411969
[TBL] [Abstract][Full Text] [Related]
33. How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis.
Abouassaly R; Finelli A; Tomlinson GA; Urbach DR; Alibhai SM
BJU Int; 2011 Dec; 108(11):1806-12. PubMed ID: 21599823
[TBL] [Abstract][Full Text] [Related]
34. Partial nephrectomy provides equivalent oncologic outcomes and better renal function preservation than radical nephrectomy for pathological T3a renal cell carcinoma: A meta-analysis.
Deng H; Fan Y; Yuan F; Wang L; Hong Z; Zhan J; Zhang W
Int Braz J Urol; 2021; 47(1):46-60. PubMed ID: 32271510
[TBL] [Abstract][Full Text] [Related]
35. Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group).
Cerrato C; Meagher MF; Autorino R; Simone G; Yang B; Uzzo RG; Kutikov A; Porpiglia F; Capitanio U; Montorsi F; Porter J; Beksac AT; Puri D; Nguyen M; Wang L; Hakimi K; Dhanji S; Liu F; Cerruto MA; Pandolfo SD; Minervini A; Lau C; Monish A; Eun D; Mottrie A; Mir C; Sundaram C; Antonelli A; Kaouk J; Derweesh IH
Minerva Urol Nephrol; 2023 Aug; 75(4):425-433. PubMed ID: 37530659
[TBL] [Abstract][Full Text] [Related]
36. Does Reduced Renal Function Predispose to Cancer-specific Mortality from Renal Cell Carcinoma?
Palacios DA; Zabor EC; Munoz-Lopez C; Roversi G; Mahmood F; Abramczyk E; Kelly M; Wilson B; Abouassaly R; Campbell SC
Eur Urol; 2021 Jun; 79(6):774-780. PubMed ID: 33678521
[TBL] [Abstract][Full Text] [Related]
37. Is partial nephrectomy worth performing compared to radical nephrectomy for small, localised renal cortical tumours in geriatric patients?
Lam JKJ; Tan SY; Chong KT
Singapore Med J; 2020 Apr; 61(4):190-193. PubMed ID: 31680178
[TBL] [Abstract][Full Text] [Related]
38. Three-dimensional reconstructive kidney volume analyses according to the endophytic degree of tumors during open partial or radical nephrectomy.
Park DS; Hong YK; Lee SR; Hwang JH; Kang MH; Oh JJ
Int Braz J Urol; 2016; 42(1):37-46. PubMed ID: 27120779
[TBL] [Abstract][Full Text] [Related]
39. Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR.
Reix B; Bernhard JC; Patard JJ; Bigot P; Villers A; Suer E; Vuong NS; Verhoest G; Alimi Q; Beauval JB; Benoit T; Nouhaud FX; Lenormand C; Hamidi N; Cai J; Eto M; Larre S; El Bakhri A; Ploussard G; Hung A; Koutlidis N; Schneider A; Carrouget J; Droupy S; Marchal S; Doerfler A; Seddik S; Matsugasumi T; Orsoni X; Descazeaud A; Pfister C; Bensalah K; Soulie M; Gill I; Flamand V;
Prog Urol; 2018 Mar; 28(3):146-155. PubMed ID: 29331568
[TBL] [Abstract][Full Text] [Related]
40. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T2 or Higher Stage Renal Tumors: A Systematic Review and Meta-Analysis.
Huang R; Zhang C; Wang X; Hu H
Front Oncol; 2021; 11():680842. PubMed ID: 34178668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
